Abstract:The in vitro dissolution mechanism of an amorphous solid dispersion (ASD) remains elusive and highly individualized, yet rational design of ASDs with optimal performance and prediction of their in vitro/in vivo performance are very much desirable in the pharmaceutical industry. To this end, we carried out comprehensive investigation of various ASD systems of griseofulvin, felodipine, and ketoconazole, in PVP-VA or HPMC-AS at different drug loading. Physiochemical properties and processes related to drug-polymer-water interaction, including the drug crystallization tendency in aqueous medium, drug-polymer interaction before and after moisture exposure, supersaturation of drug in the presence of polymer, polymer dissolution kinetics, etc., were characterized and correlated with the dissolution performance of ASDs at different dose and different drug/polymer ratio. It was observed that ketoconazole/HPMC-AS ASD outperformed all other ASDs in various dissolution conditions, which was attributed to the drugs low crystallization tendency, the strong ketoconazole/HPMC-AS interaction and the robustness of this interaction against water disruption, the dissolution rate and the availability of HPMC-AS in solution, and the ability of HPMC-AS in maintaining ketoconazole supersaturation. It was demonstrated that all these properties have implications for the dissolution performance of various ASD systems, and further quantification of them could be used as potential predictors for in vitro dissolution of ASDs. For all ASDs investigated, HPMC-AS systems performed better than, or at least comparably with, their PVP-VA counterparts, regardless of the drug loading or dose. This observation cannot be solely attributed to the ability of HPMC-AS in maintaining drug supersaturation. We also conclude that, for fast crystallizers without strong drug-polymer interaction, the only feasible option to improve dissolution might be to lower the dose and the drug loading in the ASD. In this study, we implemented an ASD/water Flory-Huggins parameter plot, which might assist in revealing the physical nature of the drug-polymer interaction. We also introduced supersaturation parameter and dissolution performance parameter as two quantitative measurements to compare the abilities of polymers in maintaining drug supersaturation, and the dissolution performance of various solid dispersions, respectively.

Insight into the State Evolution of Norfloxacin As a Function of Drug Concentration in Norfloxacin-Vinylpyrrolidone/Hydroxypropyl Methylcellulose/Hydroxypropyl Methylcellulose Phthalate Solid Dispersions

Investigation of Drug–Polymer Miscibility, Molecular Interaction, and Their Effects on the Physical Stabilities and Dissolution Behaviors of Norfloxacin Amorphous Solid Dispersions

Norfloxacin Co-amorphous Salt Systems: Effects of Molecular Descriptors on the Formation and Physical Stability of Co-amorphous Systems

Preparation and Stability Study of Norfloxacin-Loaded Solid Lipid Nanoparticle Suspensions.

Particle size control and the interactions between drug and stabilizers in an amorphous nanosuspension system

Revealing the roles of polymers in supersaturation stabilization from the perspective of crystallization behaviors: A case of nimodipine

Drug-polymer-water interaction and its implication for the dissolution performance of amorphous solid dispersions.

High drug-loaded amorphous solid dispersions of a poor glass forming drug: The impact of polymer type and cooling rate on amorphous drug behaviour

Investigating the Interaction Pattern and Structural Elements of a Drug-Polymer Complex at the Molecular Level.

Preparation and in Vitro, in Vivo Evaluations of Norfloxacin-Loaded Solid Lipid Nanopartices for Oral Delivery

Effect Of Polymeric Excipients On Nucleation And Crystal Growth Kinetics Of Amorphous Fluconazole

Effects of preparing techniques and aging on dissolution behavior of the solid dispersions of NF/Soluplus/Kollidon SR: identification and classification by a combined analysis by FT-IR spectroscopy and computational approaches.

Solid-State Spectroscopic Investigation of Molecular Interactions Between Clofazimine and Hypromellose Phthalate in Amorphous Solid Dispersions.

Impact of Polymer Enrichment at the Crystal-Liquid Interface on Crystallization Kinetics of Amorphous Solid Dispersions.

The role of polymer concentration on the molecular mobility and physical stability of nifedipine solid dispersions

Solubilities of crystalline drugs in polymers: an improved analytical method and comparison of solubilities of indomethacin and nifedipine in PVP, PVP/VA, and PVAc

Solvent-mediated amorphous-to-crystalline transformation of nitrendipine in amorphous particle suspensions containing polymers.

Quantitative Analysis of Physical Stability Mechanisms of Amorphous Solid Dispersions by Molecular Dynamic Simulation

Two Novel Hydrate Salts of Norfloxacin with Phenolic Acids and Their Physicochemical Properties

Facile preparation of solid dispersions by dissolving drugs in <i>N</i>-vinyl-2-pyrrolidone and photopolymerization

Mechanochemically Induced Solid-State Transformations of Levofloxacin